ASX - By Stock
|
AVE |
Re:
Ann: Avecho commences Phase III insomnia trial
|
|
Hill Billy 55
|
16 |
4.4K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
16
|
4.4K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho commences Phase III insomnia trial
|
|
Hill Billy 55
|
16 |
4.4K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
16
|
4.4K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
Hill Billy 55
|
40 |
8.7K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
40
|
8.7K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
Hill Billy 55
|
40 |
8.7K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
40
|
8.7K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
Hill Billy 55
|
92 |
26K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
92
|
26K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phase III Clinical Trial Investor Webinar
|
|
Hill Billy 55
|
92 |
26K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
92
|
26K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: December 2023 Quarterly Activities Report & Appendix 4C
|
|
Hill Billy 55
|
8 |
2.3K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
8
|
2.3K
|
2
|
|
ASX - By Stock
|
AVE |
Shareholder Email 19 December 2023
|
|
Hill Billy 55
|
16 |
4.2K |
13 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
16
|
4.2K
|
13
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen 2023 AGM - Chairs address and CEOs presentation
|
|
Hill Billy 55
|
3 |
1.7K |
11 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
3
|
1.7K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Annual Report to Shareholders
|
|
Hill Billy 55
|
11 |
5.4K |
0 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
11
|
5.4K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Change in substantial holding
|
|
Hill Billy 55
|
3 |
1.1K |
4 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen FY2023 results, following the science
|
|
Hill Billy 55
|
11 |
3.9K |
1 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
11
|
3.9K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
Hill Billy 55
|
160 |
73K |
1 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
160
|
73K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Withdrawal of AGM Resolutions 5(c) and 5(d)
|
|
Hill Billy 55
|
2 |
1.4K |
2 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
2
|
1.4K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
Hill Billy 55
|
160 |
73K |
0 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
160
|
73K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
Hill Billy 55
|
70 |
23K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Important 10 Year Anniversary coming up for (POH) AVE
|
|
Hill Billy 55
|
13 |
3.1K |
1 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
13
|
3.1K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
Hill Billy 55
|
71 |
21K |
3 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
71
|
21K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: December 2022 Quarterly Activities Report & Appendix 4C
|
|
Hill Billy 55
|
17 |
4.8K |
1 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
17
|
4.8K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
2023 A Defining Year
|
|
Hill Billy 55
|
26 |
6.7K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
26
|
6.7K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
2023 A Defining Year
|
|
Hill Billy 55
|
26 |
6.7K |
0 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
26
|
6.7K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
Hill Billy 55
|
68 |
15K |
1 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
68
|
15K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Athenex submits Avecho's phytonadione to FDA pre-IND
|
|
Hill Billy 55
|
68 |
15K |
8 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
68
|
15K
|
8
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE license agreement for US recreational cannabis market
|
|
Hill Billy 55
|
125 |
29K |
2 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
125
|
29K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE license agreement for US recreational cannabis market
|
|
Hill Billy 55
|
125 |
29K |
1 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
125
|
29K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE license agreement for US recreational cannabis market
|
|
Hill Billy 55
|
125 |
29K |
4 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
125
|
29K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho receives ethics approval for Phase III CBD trial
|
|
Hill Billy 55
|
71 |
21K |
7 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
71
|
21K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE signs development agreement with Perrigo
|
|
Hill Billy 55
|
28 |
6.6K |
2 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
28
|
6.6K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
A bit more about Epidiolex
|
|
Hill Billy 55
|
8 |
2.3K |
4 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
8
|
2.3K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: September 2022 Quarterly Activities Report & Appendix 4C
|
|
Hill Billy 55
|
9 |
3.0K |
1 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Increased CBD absorption in dogs vs commercial comparator
|
|
Hill Billy 55
|
43 |
9.4K |
0 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
43
|
9.4K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Increased CBD absorption in dogs vs commercial comparator
|
|
Hill Billy 55
|
43 |
9.4K |
2 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
43
|
9.4K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chair's Address and CEO Presentation
|
|
Hill Billy 55
|
35 |
12K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
35
|
12K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AVE license agreement for US recreational cannabis market
|
|
Hill Billy 55
|
125 |
29K |
3 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
125
|
29K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Arthritis TPM Cannabis gel
|
|
Hill Billy 55
|
43 |
9.0K |
2 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
43
|
9.0K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chair's Address and CEO Presentation
|
|
Hill Billy 55
|
35 |
12K |
1 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
35
|
12K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Chair's Address and CEO Presentation
|
|
Hill Billy 55
|
35 |
12K |
0 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
35
|
12K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
CBD Safety Study Findings
|
|
Hill Billy 55
|
4 |
1.5K |
1 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
4
|
1.5K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
2 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
54
|
20K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: March 2022 Quarterly Activities Report & Appendix 4C
|
|
Hill Billy 55
|
4 |
1.9K |
1 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
54
|
20K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
1 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
54
|
20K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
0 |
27/04/22 |
27/04/22 |
ASX - By Stock
|
54
|
20K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
2 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
54
|
20K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Something's brewing
|
|
Hill Billy 55
|
54 |
20K |
5 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
54
|
20K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Positive results from AVE's topical CBD pain study
|
|
Hill Billy 55
|
74 |
18K |
1 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
74
|
18K
|
1
|
|
Charts
|
AVE |
Re:
AVE + AVEO Charts
|
|
Hill Billy 55
|
67 |
20K |
0 |
05/04/22 |
05/04/22 |
Charts
|
67
|
20K
|
0
|
|
Charts
|
AVE |
Re:
AVE + AVEO Charts
|
|
Hill Billy 55
|
67 |
20K |
4 |
04/04/22 |
04/04/22 |
Charts
|
67
|
20K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Positive results from AVE's topical CBD pain study
|
|
Hill Billy 55
|
74 |
18K |
1 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
74
|
18K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Dosing begins in topical CBD pain study
|
|
Hill Billy 55
|
13 |
4.3K |
0 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
13
|
4.3K
|
0
|
|